Showing results (31-40 of 648) with videos related to
Sort By:
Pageof 65
Urological Research|January 1, 1996
The 9p21 region in bladder cancer cell lines: large homozygous deletion inactivate the CDKN2, CDKN2B and MTAP genesW M Stadler, O I OlopadeClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2010
Pazopanib in renal cell carcinomaJames E Ward, Walter M StadlerSeminars in Urologic Oncology|March 21, 1998
New chemotherapy regimens for advanced bladder cancerS O Fagbemi, W M StadlerCurrent Oncology Reports|February 19, 2005
Novel kinase inhibitors in renal cell carcinoma: progressive development of static agentsApurva A Desai, Walter M StadlerCurrent Urology Reports|February 17, 2006
Novel kinase inhibitors in renal cell carcinoma: progressive development of static agentsApurva A Desai, Walter M StadlerAdvances in Urology|February 5, 2009
The role of chemotherapy in upper tract urothelial carcinomaPeter H O'Donnell, Walter M StadlerMolecular Nutrition & Food Research|June 10, 2006
In silico predictability of allergenicity: from amino acid sequence via 3-D structure to allergenicityRob C Aalberse, Beda M StadlerClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2012
Pharmacogenomics in early-phase oncology clinical trials: is there a sweet spot in phase II?Peter H O'Donnell, Walter M StadlerClinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2024
There Is More to Length of Survival Than Survival: Endpoints in Oncology TrialsWalter M Stadler, Theodore G KarrisonFASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 24, 2003
Allergenicity prediction by protein sequenceMichael B Stadler, Beda M StadlerPageof 65